Skip to main content
. 2022 Nov 16;23:942. doi: 10.1186/s13063-022-06833-5
Enrolment Post-allocation Close-out
After consent After randomisation Treatment 14 weeks after randomisation 26 weeks after randomisation
Timepoint: Baseline Post-treatment Follow-up
Enrolment Eligibility screen X
Informed consent X
Allocation X
Demographic information X
Interventions OSI X
C-TAU X
Assessments
 Child report
  Symptom measure RCADS-C X X X
  Functional impairment CAIS-C X X X
  Adverse Events AE Self-report X X
 Parent report
  Symptom measures RCADS-P X X X
SCAS-P-8 X X X
  Functional impairment CAIS-P X X X
ORS X X X
  Co-morbid problems SDQ-P X X X
  Pandemic Anxiety Scale PAS X X X
 Treatment acceptability Credibility and Expectation of Improvement scale X X
 Adverse events AE Self-report X X
 Health economics CSRI X X X
EQ-5D-5L- P X X X
CHU-9D (YP proxy) X X X
CAIS-P X X X

 OSI+therapist support ARM ONLY

Measures collected during treatment (parent only)

RCADS-P X
SCAS-P-8 X
CAIS-P X
ORS X
SRS X
GBOs X
 Qualitative interviews X (subgroup of participants interviewed once each between 14 and 26 weeks).
 Therapist Logs X X X